Public Health & Safety: India’s drug regulator flagged a widely used rabies vaccine batch (Abhayrab, KE25012) as substandard and potentially spurious after a potency failure, prompting “strict vigilance” by state drug authorities. China–US Business Diplomacy: Xi Jinping is set to travel to Washington with a large CEO delegation, aiming to signal support for investment ties amid heightened US scrutiny of Chinese firms. Tourism Industry Strategy: Japan’s JTB plans to invest about $3.83bn through 2035, pursuing acquisitions to grow globally as domestic travel slows. Regional Tourism Collaboration: PATA urged East Asia destinations to stop competing for the same visitors and instead expand the market together via a “Super 10” model under EATOF, including shared marketing and tech. Travel Payments & Fintech: Axis Bank and Scapia launched a co-branded travel credit card for India’s digital travellers, bundling rewards and booking in one app. Disaster Response & Mobility: India said it has sent ~95 tonnes of relief material to Nepal after Himalayan flash floods, with forensic and rescue personnel deployed. Cross-Border Travel Disruption: China imposed tight movement restrictions into flood-hit Kyirong in occupied Tibet, limiting civilian access to designated relief personnel. Aviation/Travel Ops: Air India’s Phuket–Delhi pilot case is under scrutiny after an AAIB preliminary report said the pilot used drugs, with DGCA action requested. MICE & Trade: Sri Lanka promoted MICE tourism at BLTM 2026, holding meetings with hosted buyers from India and other markets.